Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease

British Journal of Haematology

Volumn 155, Issue 2, 2011, Pages 263-267

  Quinn, Charles T ^a   Stuart, Marie J ^b   Kesler, Karen ^c   Ataga, Kenneth I ^d   Wang, Winfred C ^e   Styles, Lori ^f   Smith Whitley, Kim ^g   Wun, Ted ^h   Raj, Ashok ⁱ   Hsu, Lewis L ^j   Krishnan, Suba ^b   Kuypers, Frans A ^f   Setty, Yamaja ^b   Rhee, Seungshin ^c   Key, Nigel S ^d   Buchanan, George R ^k  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c RHO INC   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF LOUISVILLE   (United States)

^j CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^k UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

more..

Author keywords

Acute chest syndrome; Biomarkers; Corticosteroid; L selectin; Sickle cell disease

Indexed keywords

DEXAMETHASONE; L SELECTIN; NARCOTIC ANALGESIC AGENT; OXYGEN; PLACEBO;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEASIBILITY STUDY; HUMAN; LENGTH OF STAY; LEUKOCYTOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SICKLE CELL ANEMIA; THORAX PAIN;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BETA-THALASSEMIA; C-REACTIVE PROTEIN; CELL ADHESION MOLECULES; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; OXYGEN INHALATION THERAPY; SICKLE CELL TRAIT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80053570618     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08827.x     Document Type: Article

References (15)

1. Begg, C.B. & Iglewicz, B. (1980) A treatment allocation procedure for sequential clinical trials. Biometrics, 36, 81-90.
2. Bernini, J.C., Rogers, Z.R., Sandler, E.S., Reisch, J.S., Quinn, C.T. & Buchanan, G.R. (1998) Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood, 92, 3082-3089.
3. Griffin, T.C., McIntire, D. & Buchanan, G.R. (1994) High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. New England Journal of Medicine, 330, 733-737.
4. Isakoff, M.S., Lillo, J.A. & Hagstrom, J.N. (2008) A single-institution experience with treatment of severe acute chest syndrome: lack of rebound pain with dexamethasone plus transfusion therapy. Journal of Pediatric Hematology/oncology, 30, 322-325.
5. Key, N.S., Slungaard, A., Dandelet, L., Nelson, S.C., Moertel, C., Styles, L.A., Kuypers, F.A. & Bach, R.R. (1998) Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood, 91, 4216-4223.
6. Krishnan, S., Siegel, J., Pullen, Jr, G., Hevelow, M., Dampier, C. & Stuart, M. (2008) Increased von Willebrand factor antigen and high molecular weight multimers in sickle cell disease associated with nocturnal hypoxemia. Thrombosis Research, 122, 455-458.
7. Krishnan, S., Setty, Y., Betal, S.G., Vijender, V., Rao, K., Dampier, C. & Stuart, M. (2010) Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises. British Journal of Haematology, 148, 797-804.
8. Kumar, R., Qureshi, S., Mohanty, P., Rao, S.P. & Miller, S.T. (2010) A short course of prednisone in the management of acute chest syndrome of sickle cell disease. Journal of Pediatric Hematology/Oncology, 32, e91-e94.
9. Nabel, E.G. & Shurin, S.B. (2008) A recommitment to sickle cell disease research. Blood, 111, 4852-4853.
10. Okpala, I. (2004) The intriguing contribution of white blood cells to sickle cell disease - a red cell disorder. Blood Reviews, 18, 65-73.
11. Pocock, S.J. & Simon, R. (1975) Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics, 31, 103-115.
12. Setty, B.N., Stuart, M.J., Dampier, C., Brodecki, D. & Allen, J.L. (2003) Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet, 362, 1450-1455.
13. Stuart, M.J. & Setty, B.N. (1999) Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Blood, 94, 1555-1560.
14. Vichinsky, E.P., Styles, L.A., Colangelo, L.H., Wright, E.C., Castro, O. & Nickerson, B. (1997) Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood, 89, 1787-1792.
15. Walker, G., Pfeilschifter, J. & Kunz, D. (1997) Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation. Journal of Biological Chemistry, 272, 16679-16687.